Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Tvedt THA"'
Autor:
Fageräng B; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Department of Clinical Immunology, Laboratory of Molecular Medicine, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Cyranka L; Department of Clinical Immunology, Laboratory of Molecular Medicine, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Schjalm C; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway., McAdam KE; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway., Larsen CS; Department of Hematology, Oslo University Hospital, Oslo, Norway., Heinzelbecker J; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway., Gedde-Dahl T; Department of Hematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Würzner R; Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria., Espevik T; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Tjønnfjord GE; Department of Hematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Garred P; Department of Clinical Immunology, Laboratory of Molecular Medicine, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Barratt-Due A; Division of Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway., Tvedt THA; Department of Hematology, Oslo University Hospital, Oslo, Norway., Mollnes TE; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Research Laboratory, Nordland Hospital, Bodø, Norway.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Jun 13; Vol. 15, pp. 1422370. Date of Electronic Publication: 2024 Jun 13 (Print Publication: 2024).
Autor:
Aarstad HH; Department of Otolaryngology/Head and Neck Surgery, Haukeland University Hospital, 5009 Bergen, Norway.; Department of Surgery, Haraldsplass Deaconal Hospital, 5009 Bergen, Norway., Moe SEE; Department of Otolaryngology/Head and Neck Surgery, Haukeland University Hospital, 5009 Bergen, Norway., Lybak S; Department of Otolaryngology/Head and Neck Surgery, Haukeland University Hospital, 5009 Bergen, Norway.; Department of Clinical Medicine, Faculty of Medicine, University of Bergen, 5007 Bergen, Norway., Bruserud Ø; Section for Haematology, Department of Medicine, Haukeland University Hospital, 5009 Bergen, Norway., Tvedt THA; Department of Haematology, Oslo University Hospital, Rikshospitalet, 0372 Oslo, Norway., Aarstad HJ; Department of Otolaryngology/Head and Neck Surgery, Haukeland University Hospital, 5009 Bergen, Norway.; Department of Clinical Medicine, Faculty of Medicine, University of Bergen, 5007 Bergen, Norway.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Apr 12; Vol. 16 (8). Date of Electronic Publication: 2024 Apr 12.
Autor:
Nørgaard JN; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway. jaknoe@ous-hf.no.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. jaknoe@ous-hf.no.; KG Jebsen Center for B cell malignancies, University of Oslo, Oslo, Norway. jaknoe@ous-hf.no., Moore KLF; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; KG Jebsen Center for B cell malignancies, University of Oslo, Oslo, Norway.; Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway., Slørdahl TS; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Hematology, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway., Vik A; Department of Hematology, University Hospital of North Norway, Tromsø, Norway.; Institute of Clinical Medicine, The Arctic University of Norway, UiT, Tromsø, Norway., Tvedt THA; Department of Hematology, Oslo University Hospital, Oslo, Norway.; Clinic for Medicine, Haukeland University Hospital, Bergen, Norway., Schjesvold F; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Center for B cell malignancies, University of Oslo, Oslo, Norway.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Apr 09; Vol. 14 (1), pp. 60. Date of Electronic Publication: 2024 Apr 09.
Autor:
Rørvik SD; Department of Cardiology, Haukeland University Hospital, Bergen, Norway., Torkildsen S; Department of Haematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Bruserud Ø; Acute Leukemia Research Group, Department of Clinical Science, University of Bergen, Bergen, Norway.; Section for Hematology, Department of Medicine, Haukeland University Hospital, Bergen, Norway., Tvedt THA; Department of Haematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. totved@ous-hf.no.
Publikováno v:
Annals of hematology [Ann Hematol] 2024 Apr; Vol. 103 (4), pp. 1103-1119. Date of Electronic Publication: 2024 Mar 06.
Autor:
Tsykunova G; Department of Medicine Haukeland University Hospital, Bergen, Norway., Kristensen E; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway., Stray-Pedersen A; The National Unit for Newborn Screening, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway., Bruserud Ø; Department of Anesthesiology and Intensive Care, Haukeland University Hospital, Bergen, Norway., Sørensen IW; Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway., Bruserud Ø; Department of Medicine Haukeland University Hospital, Bergen, Norway.; Section for Hematology, Department of Clinical Science, University of Bergen, Bergen, Norway., Tvedt THA; Department of Medicine Haukeland University Hospital, Bergen, Norway.; Department of Haematology, Oslo University Hospital, Oslo, Norway.
Publikováno v:
Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2265187. Date of Electronic Publication: 2023 Oct 05.
Autor:
Röth A; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Broome CM; Division of Hematology, MedStar Georgetown University Hospital, Washington, DC., Barcellini W; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Tvedt THA; Department of Medicine, Section for Hematology, Haukeland University Hospital, Bergen, Norway., Miyakawa Y; Department of Hematology, Saitama Medical University Hospital, Saitama, Japan., D'Sa S; UCLH Centre for Waldenström's Macroglobulinemia and Related Conditions, University College London Hospitals NHS Foundation Trust, London, United Kingdom., Cella D; Department of Medical Social Sciences, Center for Patient-Centered Outcomes, Institute for Public Health and Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL., Bozzi S; Sanofi, Chilly-Mazarin, France., Jayawardene D; Sanofi, Cambridge, MA., Yoo R; Sanofi, Cambridge, MA., Shafer F; Sanofi, Cambridge, MA., Wardęcki M; Sanofi, Warszawa, Poland., Weitz IC; Jane Anne Nohl Division of Hematology, Department of Medicine, University of Southern California-Keck School of Medicine, Los Angeles, CA.
Publikováno v:
Blood advances [Blood Adv] 2023 Oct 10; Vol. 7 (19), pp. 5890-5897.
Autor:
Bartaula-Brevik S; Acute Leukemia Research Group, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway., Leitch C; Department of Clinical Science, Centre for Pharmacy, University of Bergen, 5015 Bergen, Norway., Hernandez-Valladares M; Acute Leukemia Research Group, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.; The Proteomics Facility of the University of Bergen (PROBE), University of Bergen, 5009 Bergen, Norway.; The Department of Biomedicine, University of Bergen, 5009 Bergen, Norway.; Department of Physical Chemistry, University of Granada, Avenida de la Fuente Nueva S/N, 18071 Granada, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, 18012 Granada, Spain., Aasebø E; Acute Leukemia Research Group, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.; The Proteomics Facility of the University of Bergen (PROBE), University of Bergen, 5009 Bergen, Norway.; The Department of Biomedicine, University of Bergen, 5009 Bergen, Norway., Berven FS; The Proteomics Facility of the University of Bergen (PROBE), University of Bergen, 5009 Bergen, Norway.; The Department of Biomedicine, University of Bergen, 5009 Bergen, Norway., Selheim F; The Proteomics Facility of the University of Bergen (PROBE), University of Bergen, 5009 Bergen, Norway.; The Department of Biomedicine, University of Bergen, 5009 Bergen, Norway., Brenner AK; Acute Leukemia Research Group, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway., Rye KP; Acute Leukemia Research Group, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway., Hagen M; Acute Leukemia Research Group, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway., Reikvam H; Acute Leukemia Research Group, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.; Section for Hematology, Department of Medicine, Haukeland University Hospital, 5021 Bergen, Norway., McCormack E; Department of Clinical Science, Centre for Pharmacy, University of Bergen, 5015 Bergen, Norway., Bruserud Ø; Acute Leukemia Research Group, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.; Section for Hematology, Department of Medicine, Haukeland University Hospital, 5021 Bergen, Norway., Tvedt THA; Acute Leukemia Research Group, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.; Section for Hematology, Department of Medicine, Haukeland University Hospital, 5021 Bergen, Norway.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2023 Aug 25; Vol. 12 (17). Date of Electronic Publication: 2023 Aug 25.
Autor:
Röth A; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Barcellini W; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., D'Sa S; UCLH Centre for Waldenström's Macroglobulinemia and Related Conditions, University College London Hospitals NHS Foundation Trust, London, UK., Miyakawa Y; Department of Hematology, Saitama Medical University, Saitama, Japan., Broome CM; Division of Hematology, MedStar Georgetown University Hospital, Washington, DC, USA., Michel M; Henri-Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, UPEC, Créteil, France., Kuter DJ; Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Jilma B; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria., Tvedt THA; Section for Hematology, Department of Medicine, Haukeland University Hospital, Bergen, Norway., Weitz IC; Keck School of Medicine of USC, Los Angeles, California, USA., Yoo R; Sanofi, Cambridge, Massachusetts, USA., Jayawardene D; Sanofi, Cambridge, Massachusetts, USA., Vagge DS; IQVIA, Bangalore, India., Kralova K; Sanofi, Paris, France., Shafer F; Sanofi, Bridgewater, New Jersey, USA., Wardȩcki M; Sanofi, Warsaw, Poland., Lee M; Sanofi, Bridgewater, New Jersey, USA., Berentsen S; Department of Research and Innovation, Haugesund Hospital, Haugesund, Norway.
Publikováno v:
American journal of hematology [Am J Hematol] 2023 Aug; Vol. 98 (8), pp. 1246-1253. Date of Electronic Publication: 2023 May 29.
Autor:
Federico L; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Tvedt THA; Department of Haematology, Oslo University Hospital, Oslo, Norway., Gainullin M; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Osen JR; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Chaban V; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Lund KP; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Tietze L; Department of Immunology, Oslo University Hospital, Oslo, Norway.; ImmunoLingo Convergence Center, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Tran TT; Department of Immunology, Oslo University Hospital, Oslo, Norway.; ImmunoLingo Convergence Center, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Lund-Johansen F; Department of Immunology, Oslo University Hospital, Oslo, Norway.; ImmunoLingo Convergence Center, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Kared H; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Lind A; Department of Microbiology, Oslo University Hospital, Oslo, Norway., Vaage JT; ImmunoLingo Convergence Center, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Stratford R; NEC OncoImmunity AS, Oslo, Norway., Tennøe S; NEC OncoImmunity AS, Oslo, Norway., Malone B; NEC OncoImmunity AS, Oslo, Norway., Clancy T; NEC OncoImmunity AS, Oslo, Norway., Myhre AEL; Department of Haematology, Oslo University Hospital, Oslo, Norway.; ImmunoLingo Convergence Center, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Gedde-Dahl T; Department of Haematology, Oslo University Hospital, Oslo, Norway., Munthe LA; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Jul 07; Vol. 14, pp. 1210899. Date of Electronic Publication: 2023 Jul 07 (Print Publication: 2023).
Autor:
Tislevoll BS; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway., Hellesøy M; Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Helse Bergen HF, Bergen, Norway., Fagerholt OHE; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway., Gullaksen SE; Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Helse Bergen HF, Bergen, Norway., Srivastava A; Genome Core Facility, Clinical Laboratory, K2 Haukeland University Hospital, Bergen, Norway., Birkeland E; The Proteomics Facility of the University of Bergen (PROBE), University of Bergen, Bergen, Norway., Kleftogiannis D; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway.; Centre for Cancer Biomarkers and Computational Biology Unit, Department of Informatics, University of Bergen, Bergen, Norway., Ayuda-Durán P; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0379, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318, Oslo, Norway., Piechaczyk L; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0379, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway., Tadele DS; Department of Molecular Genetics, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway.; Department of Translational Hematology and Oncology Research, Cleveland Clinic, OH, 44106, USA., Skavland J; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway., Baliakas P; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Hovland R; Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway., Andresen V; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway., Seternes OM; Department of Pharmacy, UiT-The Arctic University of Norway, 9037, Tromsø, Norway., Tvedt THA; Department of Hematology, Oslo University Hospital, Oslo, Norway., Aghaeepour N; Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, 94121, USA.; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, 94121, USA.; Department of Biomedical Informatics, Stanford University School of Medicine, Stanford, CA, 94121, USA., Gavasso S; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway.; Centre for Clinical Treatment Research (NeuroSysMed), Department of Clinical Science, University of Bergen, Bergen, Norway., Porkka K; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland., Jonassen I; Centre for Cancer Biomarkers and Computational Biology Unit, Department of Informatics, University of Bergen, Bergen, Norway., Fløisand Y; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318, Oslo, Norway.; Department of Hematology, Oslo University Hospital, Oslo, Norway., Enserink J; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0379, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318, Oslo, Norway.; Section for Biochemistry and Molecular Biology, Faculty of Mathematics and Natural Sciences, University of Oslo, 0037, Oslo, Norway., Blaser N; Department of Informatics, University of Bergen, Bergen, Norway. nello.blaser@uib.no., Gjertsen BT; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway. bjorn.gjertsen@uib.no.; Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Helse Bergen HF, Bergen, Norway. bjorn.gjertsen@uib.no.
Publikováno v:
Nature communications [Nat Commun] 2023 Mar 30; Vol. 14 (1), pp. 1767. Date of Electronic Publication: 2023 Mar 30.